Drug interaction classified as: metabolism
Source: DDInter
Calcium Channel Blocker · Cardiovascular Agent
Isradipine, a calcium channel antagonist, produces its effects by binding to the alpha-1 subunit of the L-type Ca2+ channels. This binding reduces Ca2+ flux through the channel, thereby altering the plateau phase of the cardiac action potential and decreasing contraction in cardiac and vascular smooth muscle cells.
Drug interaction classified as: metabolism
Source: DDInter
Drug interaction classified as: metabolism
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Clinical effect not specified
Source: DDInter
Drug interaction classified as: metabolism
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Continue into a citation-backed clinical answer with the drug context already attached.
Textbook-sourced·Sources: Goodman & Gilman 14e, Katzung·Updated: 2026-05-10